Author

Hannah Mager

ORCID 0009-0002-1349-6220Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Amanda L. Halfond· 1 shared Hillary HoytiD· 1 shared Huan Qiu· 1 shared Huanying Gary Ge· 1 shared John R. LydeardiD· 1 shared Julia Etchin· 1 shared Julian Scherer· 1 shared Juliana M. Xavier-FerrucioiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amanda L. Halfond

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 21, 2025

Integrating Human Genetics and Protective Genome Editing to Enable ADGRE2-Directed AML Therapy

Yonina Keschner, Julia Etchin, Mariana Camoesas Silva…·John R. Lydeard

This study evaluates ADGRE2 as an AML target, showing efficient gene editing in HSPCs to protect against myelotoxicity and developing ADGRE2-specific CAR T cells for therapy.

DOI 10.1101/2025.08.21.671614

humangenetic perturbation / CRISPR

𝕏 PostBluesky